Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response

The antibody-dependent cellular cytotoxicity (ADCC) effector function of natural killer (NK) cells is one of the known mechanisms of action for rituximab-based anti-cancer immunotherapy. Inhibition of the ADCC function of NK cells through interactions between inhibitory killer cell immunoglobulin-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Makanga, Dhon Roméo, Jullien, Maxime, David, Gaëlle, Legrand, Nolwenn, Willem, Catherine, Dubreuil, Léa, Walencik, Alexandre, Touzeau, Cyrille, Gastinne, Thomas, Tessoulin, Benoit, Le Gouill, Steven, Mahé, Béatrice, Gagne, Katia, Chevallier, Patrice, Clemenceau, Béatrice, Retière, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204974/
https://www.ncbi.nlm.nih.gov/pubmed/34178429
http://dx.doi.org/10.1080/2162402X.2021.1936392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204974/
https://www.ncbi.nlm.nih.gov/pubmed/34178429
http://dx.doi.org/10.1080/2162402X.2021.1936392

Ejemplares similares